Search
for

    Sort by

    Research 871–900 of 1000+

    1. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases 2017 · 25 citations
    2. Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes JAAD Case Reports · 2018 · 24 citations
    3. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman Acta dermato-venereologica · 2016 · 24 citations
    4. Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata JAMA Dermatology · 2022 · 23 citations
    5. Safety concerns when using novel medications to treat alopecia Expert Opinion on Drug Safety · 2018 · 23 citations
    6. Lack of efficacy of apremilast in 9 patients with severe alopecia areata Journal of the American Academy of Dermatology · 2017 · 23 citations
    7. 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis Bioactive Materials · 2024 · 22 citations
    8. Parsing patterns: Emerging roles of tissue self-organization in health and disease Cell · 2024 · 22 citations
    9. Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient Skin appendage disorders · 2017 · 22 citations
    10. Treatment of Alopecia Areata with Simvastatin/Ezetimibe 2017 · 21 citations
    11. Alopecia Areata: An Update on Treatment Options for Children Paediatric drugs · 2017 · 21 citations
    12. Current Treatments for Alopecia Areata 2015 · 21 citations
    13. Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis Journal of the European Academy of Dermatology and Venereology · 2024 · 20 citations
    14. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    15. Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis JAAD Case Reports · 2019 · 20 citations
    16. Novedades terapéuticas en tricología Actas Dermo-Sifiliográficas · 2017 · 20 citations
    17. The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review Dermatologic therapy · 2019 · 19 citations
    18. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature Journal of cutaneous medicine and surgery · 2019 · 17 citations
    19. Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature JAAD Case Reports · 2023 · 16 citations
    20. Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models Experimental Dermatology · 2018 · 16 citations
    21. Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series Rheumatology and Therapy · 2017 · 16 citations
    22. The Changing Landscape of Alopecia Areata: The Translational Landscape Advances in Therapy · 2017 · 16 citations
    23. Excellent response to tofacitinib treatment in a patient with alopecia universalis Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2017 · 16 citations
    24. Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima Processes · 2020 · 15 citations
    25. A “hair‐raising” history of alopecia areata Experimental Dermatology · 2020 · 15 citations
    26. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen European Journal of Dermatology · 2019 · 15 citations
    27. Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review Acta Dermato Venereologica · 2023 · 14 citations
    28. Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata 2021 · 14 citations
    29. Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata Actas Dermo-Sifiliográficas · 2021 · 14 citations
    30. Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib Journal of the European Academy of Dermatology and Venereology · 2021 · 14 citations